TNSN99225A1 - Formulations de doramectine antiparasitaires et procede pour leur preparation - Google Patents
Formulations de doramectine antiparasitaires et procede pour leur preparationInfo
- Publication number
- TNSN99225A1 TNSN99225A1 TNTNSN99225A TNSN99225A TNSN99225A1 TN SN99225 A1 TNSN99225 A1 TN SN99225A1 TN TNSN99225 A TNTNSN99225 A TN TNSN99225A TN SN99225 A TNSN99225 A TN SN99225A TN SN99225 A1 TNSN99225 A1 TN SN99225A1
- Authority
- TN
- Tunisia
- Prior art keywords
- doramectin
- preparation
- formulations
- pest control
- formulation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
Abstract
L'INVENTION CONCERNE UNE FORMULATION COMPRENANT DE LA DORAMECTINE DANS UN SOLVANT COMPRENANT DE L'HUILE DE RICIN ET DE L'OLEATE D'ETHYLE OU DE L'HUILE DE COPRAH FRACTIONNEE ET DES AGENTS AUXILIAIRES SUPPLEMENTAIRES FACULTATIFS. ELLE CONCERNE EGALEMENT UN PROCEDE POUR SA PREPARATION. APPLICATION : UTILISATION DE CETTE FORMULATION POUR LUTTER CONTRE DES ENDO-OU ECTOPARASITES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9827727.0A GB9827727D0 (en) | 1998-12-16 | 1998-12-16 | Antiparasitic formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN99225A1 true TNSN99225A1 (fr) | 2005-11-10 |
Family
ID=10844352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNTNSN99225A TNSN99225A1 (fr) | 1998-12-16 | 1999-11-29 | Formulations de doramectine antiparasitaires et procede pour leur preparation |
Country Status (21)
Country | Link |
---|---|
US (1) | US6699847B2 (fr) |
EP (1) | EP1140068B1 (fr) |
JP (1) | JP3848537B2 (fr) |
AP (1) | AP9901699A0 (fr) |
AR (1) | AR019499A1 (fr) |
AT (1) | ATE269074T1 (fr) |
AU (1) | AU762892B2 (fr) |
BR (1) | BR9916265A (fr) |
CA (1) | CA2355102C (fr) |
DE (1) | DE69918165T2 (fr) |
DK (1) | DK1140068T3 (fr) |
ES (1) | ES2221455T3 (fr) |
GB (1) | GB9827727D0 (fr) |
GT (1) | GT199900213A (fr) |
MA (1) | MA26710A1 (fr) |
PA (1) | PA8486601A1 (fr) |
PE (1) | PE20001244A1 (fr) |
PT (1) | PT1140068E (fr) |
TN (1) | TNSN99225A1 (fr) |
TW (1) | TW524691B (fr) |
WO (1) | WO2000035445A1 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004013142A1 (fr) * | 2002-08-02 | 2004-02-12 | The Institute Of Radiation Medicine, Academy Of Miilitary Medical Sciences, People's Liberation Army | Derive de riboflavine ainsi que sa fabrication et ses utilisations |
AU2003235019A1 (en) * | 2003-08-17 | 2005-03-03 | Sirene Call Pty Ltd | Attract-and-Kill Method of Controlling Ecto-Parasites from the Order Acarina in Livestock and Domestic Animals as well as Members of the Order Artiodactyle |
WO2010008891A2 (fr) * | 2008-06-24 | 2010-01-21 | Merial Limited | Formulations anthelminthiques |
MX2009001235A (es) * | 2008-09-19 | 2010-04-29 | Agrovet Market S A | Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina. |
JP2012517994A (ja) | 2009-02-16 | 2012-08-09 | ファイザー・インク | 高投与量ドラメクチン製剤 |
CN103417477B (zh) * | 2012-05-18 | 2015-08-05 | 中国农业科学院兰州畜牧与兽药研究所 | 一种以水为基质的多拉菌素o/w型注射液及其制备方法 |
WO2014071994A1 (fr) | 2012-11-09 | 2014-05-15 | Aktiebolaget Electrolux | Mixeur |
EA037747B1 (ru) * | 2019-04-01 | 2021-05-18 | Севиндж Аллахверди кызы АЛИЕВА | Антипаразитарное средство |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL151903B (nl) | 1965-03-24 | 1977-01-17 | Schering Ag | Werkwijze ter bereiding van een injectievloeistof door een steroid op te lossen in een mengsel van ricinusolie en benzylbenzoaat. |
DE3377064D1 (en) | 1982-12-28 | 1988-07-21 | Bayer Ag | Stable aminoglycoside-penicillin injection formulation |
DE3484584D1 (de) | 1983-10-14 | 1991-06-20 | Sumitomo Pharma | Injektionen mit verzoegerter abgabe. |
IL79765A (en) | 1985-08-23 | 1992-02-16 | Lilly Co Eli | Injectable sustained release formulations of bovine somatotropin |
ES2052173T3 (es) | 1989-04-11 | 1994-07-01 | Pfizer | Composiciones inyectables que contienen 25-cyclohexil-avermectina b1. |
NZ234802A (en) | 1989-08-14 | 1992-11-25 | Merck & Co Inc | Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals |
ES2131515T3 (es) | 1991-09-30 | 1999-08-01 | Merck & Co Inc | Formulados inyectables de accion prolongada que contienen aceite de ricino hidrogenado. |
DE4410970C1 (de) | 1994-03-29 | 1995-07-20 | Talbot Waggonfab | Wankstütze für Schienenfahrzeuge mit einer Querneigeeinrichtung |
US5580574A (en) | 1994-04-28 | 1996-12-03 | Hoffmann-La Roche Inc. | Pharmaceutical composition for transdermal delivery |
CA2233016C (fr) * | 1995-09-25 | 2007-07-17 | Ashmont Holdings Limited | Compositions anthelmintiques a base de lactone macrocyclique |
DE19613972A1 (de) * | 1996-04-09 | 1997-10-16 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl |
DE19638045A1 (de) * | 1996-09-18 | 1998-03-19 | Bayer Ag | Injektionsformulierungen von Avermectinen und Milbemycinen |
US6174540B1 (en) | 1998-09-14 | 2001-01-16 | Merck & Co., Inc. | Long acting injectable formulations containing hydrogenated caster oil |
-
1998
- 1998-12-16 GB GBGB9827727.0A patent/GB9827727D0/en not_active Ceased
-
1999
- 1999-11-22 AP APAP/P/1999/001699A patent/AP9901699A0/en unknown
- 1999-11-22 PT PT99954291T patent/PT1140068E/pt unknown
- 1999-11-22 ES ES99954291T patent/ES2221455T3/es not_active Expired - Lifetime
- 1999-11-22 AU AU10699/00A patent/AU762892B2/en not_active Ceased
- 1999-11-22 EP EP99954291A patent/EP1140068B1/fr not_active Expired - Lifetime
- 1999-11-22 CA CA002355102A patent/CA2355102C/fr not_active Expired - Fee Related
- 1999-11-22 AT AT99954291T patent/ATE269074T1/de active
- 1999-11-22 BR BR9916265-2A patent/BR9916265A/pt not_active Application Discontinuation
- 1999-11-22 JP JP2000587765A patent/JP3848537B2/ja not_active Expired - Fee Related
- 1999-11-22 WO PCT/IB1999/001854 patent/WO2000035445A1/fr active IP Right Grant
- 1999-11-22 DE DE69918165T patent/DE69918165T2/de not_active Expired - Lifetime
- 1999-11-22 DK DK99954291T patent/DK1140068T3/da active
- 1999-11-23 TW TW088120463A patent/TW524691B/zh active
- 1999-11-24 PE PE1999001183A patent/PE20001244A1/es not_active Application Discontinuation
- 1999-11-26 AR ARP990106036A patent/AR019499A1/es active IP Right Grant
- 1999-11-29 TN TNTNSN99225A patent/TNSN99225A1/fr unknown
- 1999-11-30 MA MA25859A patent/MA26710A1/fr unknown
- 1999-12-07 PA PA19998486601A patent/PA8486601A1/es unknown
- 1999-12-15 GT GT199900213A patent/GT199900213A/es unknown
-
2001
- 2001-11-07 US US10/039,608 patent/US6699847B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PE20001244A1 (es) | 2000-11-07 |
AU1069900A (en) | 2000-07-03 |
CA2355102A1 (fr) | 2000-06-22 |
DE69918165T2 (de) | 2004-10-14 |
AP9901699A0 (en) | 2001-05-22 |
DE69918165D1 (de) | 2004-07-22 |
JP2002532422A (ja) | 2002-10-02 |
PA8486601A1 (es) | 2000-09-29 |
CA2355102C (fr) | 2006-07-11 |
EP1140068A1 (fr) | 2001-10-10 |
AU762892B2 (en) | 2003-07-10 |
PT1140068E (pt) | 2004-09-30 |
EP1140068B1 (fr) | 2004-06-16 |
GB9827727D0 (en) | 1999-02-10 |
GT199900213A (es) | 2001-06-07 |
ATE269074T1 (de) | 2004-07-15 |
US6699847B2 (en) | 2004-03-02 |
DK1140068T3 (da) | 2004-07-12 |
ES2221455T3 (es) | 2004-12-16 |
AR019499A1 (es) | 2002-02-20 |
US20020142972A1 (en) | 2002-10-03 |
TW524691B (en) | 2003-03-21 |
BR9916265A (pt) | 2001-11-20 |
JP3848537B2 (ja) | 2006-11-22 |
MA26710A1 (fr) | 2004-12-20 |
WO2000035445A1 (fr) | 2000-06-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA25029A1 (fr) | Formulations antiparasitaires contenant une avermectine ou milbemycine, et procede pour leur preparation. | |
TNSN98017A1 (fr) | Derives de sulfonyluree, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TNSN99053A1 (fr) | Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant | |
TNSN99172A1 (fr) | 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
BE2015C026I2 (en) | 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens | |
EP0911321A3 (fr) | Composés pour le traitement de l'ostéoporose | |
HUT77510A (hu) | 2-[(Dihidro)pirazol-3'-il-oxi-metil]-anilid-származékok, intermedierjeik, előállításuk és alkalmazásuk, valamint hatóanyagként ezeket a vegyületeket tartalmazó állati kártevőirtó és gombaölő készítmények | |
BG104315A (en) | Prostaglandine agonists and their application for the treatment of osteal diseases | |
PL326203A1 (en) | (methylsulphonyl)phenyl-2-(5)-furanones as cox-2 inhibitors | |
CA2244785A1 (fr) | Pentafluorobenzenesulfonamides et analogues | |
TR200102817T2 (tr) | Antiinflamatuar ajanlar olarak faydalı bileşikler | |
DE69935335D1 (de) | Pyrazole als modulatoren des östrogenrezeptors | |
HUP0002956A3 (en) | Use of 4-aminopyrrole[3,2d]pyrimidines for the preparation of pharmaceutical compositions treating diseases related to an excess of neuropeptide y | |
HK1028548A1 (en) | Formulations for hydrophobic pharmaceutical agents | |
DE60138709D1 (de) | Analoge der barbitursäure als therapeutische wirkstoffe | |
DE69618820T2 (de) | 3,4-diaryl-2-hydroxy-2,5-dihydrofurane als wirkstoffvorstufen von cox-2 inhibitoren | |
EP0743066A3 (fr) | Agent cicatrisant | |
TNSN99225A1 (fr) | Formulations de doramectine antiparasitaires et procede pour leur preparation | |
WO1998058911A3 (fr) | Agonistes de prostaglandines | |
FR2787789B1 (fr) | Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations | |
BE1014502A5 (fr) | Compositions pharmaceutiques. | |
EP0953331A3 (fr) | Composition anhydre fluorée et produits cosmétiques ou de soins la contenant | |
TNSN01052A1 (fr) | Metabolites du (-) - cis - 6 - phenyl - 5 - [4 -( 2-pyrrolidine -1- yl - ethoxy) - phenyl] - 5,6,7,8- tetrahydro - naphtalene - 2 - ol et compositions les contenant | |
WO2004055201A3 (fr) | Cholesterol 24-hydroxylase (cyp46) utilisee en tant que cible therapeutique pour le traitement de la maladie d'alzheimer | |
DE69816047D1 (en) | (methylsulfonyl)phenyl-2-(5h)-furanone mit sauerstoff-bindung als cox-2-hemmer |